Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
Morning Business Report: Mortgage rates dip as housing market cools; stocks, drugmakers fall amid tariff pressures 41NBC News
There’s a bit of relief for potential homebuyers this week. (LILAMAX)- There’s a bit of relief for potential…
3 Top Healthcare Stocks to Buy in October
Novo Nordisk could get its momentum back with its oral Wegovy pill. Danaher is a proven market-beater trading…
50 European corporates backing startups on the path to growth, innovation, and global impact
Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
GLP-1 Weight-Loss Pills Could Transform Treatment
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…
Cheap, Copycat Ozempic Was Supposed to Go Away. It’s Still Everywhere.
The copycat weight-loss drugs party was supposed to be over, but it’s still raging on. Because of shortages…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
Pricing group says weight-loss drugs becoming more cost-effective
By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become…
Ozempic, other weight-loss drug makers face lawsuits. Here’s what we know
Claim: Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…